PPD clinical research business of Thermo Fisher Scientific
![PPD clinical research business of Thermo Fisher Scientific](https://www.medidata.com/wp-content/themes/md/v2/static/images/home-background.webp)
![Company Name of Partner](https://www.medidata.com/wp-content/uploads/2018/08/PPD-Part-of-TFS-01-1024x523.jpg)
The PPD clinical research business of Thermo Fisher Scientific provides services that enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Obstetrics / Gynecology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Psychiatry
- Pulmonary
- Respiratory
- Rheumatology
- Sleep
- Urology
- Vaccines
Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, we serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, we apply cutting-edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.